Skip to content
On this episode of Yahoo Finance Presents, Secretary Ben Carson joined Yahoo Finance's Sibile Marcellus to discuss the state of affairs in America, including the current coronavirus pandemic, Bank of America's statement regarding the Housing and Urban Development's disparate impact rule, President Trump and Dr. Fauci, as well as racial inequality....
(Bloomberg) -- It took 200 million pounds ($250 million) of Richard Branson’s own money to secure the rescue of his Virgin Atlantic Airways Ltd.The outlay marks the latest example of the industry’s enduring capacity to shrink fortunes, although the British billionaire may not be surprised, having once said: “If you want to be a millionaire, start with a billion dollars and launch a new airline.”The airline business has long proved irresistible to a cohort of larger-than-life tycoons. From AirAsia Group Bhd’s Tony Fernandes to JetBlue Airways Corp. founder David Neeleman, some of the world’s most celebrated entrepreneurs have built fortunes shuttling people through the sky. But with air travel dwindling in lockdown, coronavirus has battered even those long hardened to the volatility and thin margins of the capital-intensive industry.The market values of 10 large, publicly traded airlines linked to prominent magnates tracked by the Bloomberg Billionaires Index have fallen in value...
Goldman Sachs (GS) reported stronger-than-expected second-quarter earnings results on Wednesday, as surging revenues despite the pandemic buttressed the bottom line and its stock price....
Healthcare giant UnitedHealth (UNH) has reported its second quarter earning results with Q2 Non-GAAP EPS of $7.12 beating Street estimates by $1.88. Similarly GAAP EPS of $6.91 easily topped consensus expectations by $1.73.However revenue of $62.14B fell short of estimates by $1.4B, despite rising 2.5% year-over-year, as growth in serving public-sector and senior programs was partially offset by commercial enrollment declines.According to UNH earnings were substantially higher than anticipated due primarily to the unprecedented, temporary deferral of care in the company’s risk-based businesses. UNH expects these results will be offset in the quarters ahead by the assistance measures already taken, the resumption of deferred care and future COVID-19 cost and economic impacts.Encouragingly, Optum second quarter revenues and operating earnings of $32.7 billion and $2.2 billion surged from $28 billion and $2.1 billion a year ago, led by earnings growth at OptumHealth. Indeed, OptumHealth served approximately 97 million people in the second quarter, compared...
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) * Altimmune Inc (NASDAQ: ALT) (priced its $115 million worth of common stock and pre-funded warrant offering) * Beigene Ltd (NASDAQ: BGNE) * Bicycle Therapeutics PLC (NASDAQ: BCYC) * Bio-Rad Laboratories, Inc. (NYSE: BIO) * Imv Inc (NASDAQ: IMV) (provided an update on its coronavirus vaccine program) * INmune Bio Inc (NASDAQ: INMB)( announced positive interim Phase 1b data for its Alzheimer's drug) * OncoSec Medical Inc (NASDAQ: ONCS) * Qiagen NV (NYSE: QGEN) * Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) (announced initiation of clinical study of its fostamatinib for treating COVID-19 pneumonia) * TIZIANA LF SCIE/S ADR (NASDAQ: TLSA) * Vaxart Inc (NASDAQ: VXRT) * VBI Vaccines Inc (NASDAQ: VBIV)Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 14) * Acorda Therapeutics Inc (NASDAQ: ACOR) *...
Stock futures opened higher Tuesday evening after newly published data from Moderna fueled hopes that a vaccine providing protection against Covid-19 would be developed in the relative near-term....
